Fund Card

Fund Card

Aditya Birla SL Pharma & Healthcare Fund-Reg(G)

As on Dec-05-2019 change fund
10.60  down-0.08 (-0.75%)

fund objective

Investment objective of the scheme is to provide long term capital appreciation by investing in equity & equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes objectives will be achieved.

riskometer

Investors understand that their principal will be at high risk

5-Years History
financial year2017-2018
NAV in Rs (as on 22-Apr-2017)NA
Net Assets(Rs Crores) (as on 22-Apr-2017) _
Scheme Returns(%)(Absolute)NA
B'mark Returns(%)(Absolute)-14.45
Category Rank59/61
Quarterly performance - Last 5 years (Absolute Ret. in %)
financial year Q1 Q2 Q3 Q4
No Data Found
Top 10 holdings
company (%)
Sun Pharmaceutical Industries...11.05 
Cipla Ltd.9.18 
Lupin Ltd.7.92 
Alkem Laboratories Ltd.5.80 
Divis Laboratories Ltd.5.41 
Atul Ltd.5.36 
Apollo Hospitals Enterprise Ltd.4.79 
Torrent Pharmaceuticals Ltd.4.69 
Dr. Reddys Laboratories Ltd.4.52 
Aurobindo Pharma Ltd.4.19 

Category

Sector Funds

Launch Date

10-Jul-19

Scheme Benchmark

S&P BSE HEALTH CARE - TRI

AUM ( in Cr.)

170.53

portfolio price to book value

NA

investing style?

Mid Growth

fund manager?

Dhaval Shah

inception date (regular plan)

10-Jul-19

expense ratio (regular plan) %

2.71

Alpha [%]

0.02

Beta [%]

0.43

Top 10 sectors
sectors (%)
Pharmaceuticals & Drugs75.46
Hospital & Healthcare Services8.35
Chemicals 5.36
Consumer Food3.27
Insurance2.20

Historical NAV Chart with Benchmark

to go
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • maximum
performance comparision with similar schemes
scheme name investment style inception date AUM in Cr. 1W(%) 1M(%) 3M(%) 1Y(%) 3Y(%) 5Y(%) 10Y(%) since inception
Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Mid-Growth 10-Jul-2019170.53-1.030.573.31NANANANA6.00BUYSIP
Nippon India Pharma Fund(G)Mid-Growth 05-Jun-20042,429.66-0.861.154.881.671.843.6213.4119.10BUYSIP
Tata India Pharma & Healthcare Fund-Reg(G)Mid-Growth 28-Dec-2015171.04-1.411.093.516.970.14NANA-2.07BUYSIP
UTI Healthcare Fund-Reg(G)Mid-Growth 01-Aug-2005400.93-1.232.565.422.05-2.53-0.2310.7115.99BUYSIP
SBI Healthcare Opp Fund-Reg(G)Mid-Growth 14-Jul-1999936.91-1.750.975.10-0.08-5.18-0.3312.5613.74BUYSIP
DSP Healthcare Fund-Reg(G)Mid-Growth 30-Nov-2018235.17-1.501.186.287.11NANANA6.57BUYSIP
Mirae Asset Healthcare Fund-Reg(G)Mid-Growth 02-Jul-2018357.92-1.421.404.376.42NANANA5.36BUYSIP
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Mid-Growth 13-Jul-20181,339.10-1.541.495.364.39NANANA1.57BUYSIP
IDBI Healthcare Fund-Reg(G)Mid-Growth 28-Feb-201933.17-1.041.555.43NANANANA4.90BUYSIP

Copyright © 2017 Vedant Asset. All Right Reserved.

Mutual Fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not an indicator of future returns. ARN-104974